Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Gottesdiener Keith Michael Create: Alert

All | News | Filings
Date FiledTypeDescription
05/25/2023 4 Gottesdiener Keith Michael (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns: Granted 8,111 shares @ $0
Granted 12,547 options to buy @ $9.17, valued at $115.1k
04/04/2023 4 Gottesdiener Keith Michael (See Remarks) has filed a Form 4 on Prime Medicine, Inc.
Txns: Granted 497,738 options to buy @ $12.3, valued at $6.1M
10/19/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/01/2020 4 Gottesdiener Keith Michael (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns: Granted 1,595 shares @ $0
Granted 2,966 options to buy @ $72.74, valued at $215.7k
03/11/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/12/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/10/2020 4 Gottesdiener Keith Michael (CEO & President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns: Exercised 33,072 options to buy @ $4.59, valued at $151.8k
07/17/2019 4 Gottesdiener Keith Michael (CEO and President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns: Exercised 7,500 options to buy @ $4.59, valued at $34.4k
06/21/2019 4 Gottesdiener Keith Michael (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns: Granted 1,570 shares @ $0
Granted 2,174 options to buy @ $82.25, valued at $178.8k
03/19/2019 4 Gottesdiener Keith Michael (CEO & President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns: Sold 7,961 shares @ $30.04, valued at $239.1k
Sold 2,329 shares @ $30.27, valued at $70.5k
03/15/2019 4 Gottesdiener Keith Michael (CEO & President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns: Sold 7,782 shares @ $30.06, valued at $233.9k
Sold 1,506 shares @ $30.05, valued at $45.3k
02/28/2019 4 Gottesdiener Keith Michael (CEO and President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns: Sold 635 shares @ $30.13, valued at $19.1k
Sold 1,814 shares @ $30.01, valued at $54.4k
02/20/2019 4 Gottesdiener Keith Michael (CEO and President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns: Sold 12,002 shares @ $30.02, valued at $360.3k
Sold 918 shares @ $30.05, valued at $27.6k
02/15/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/24/2019 4 Gottesdiener Keith Michael (CEO and President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns: Sold 15,674 shares @ $30.05, valued at $471k
Sold 105 shares @ $30.21, valued at $3.2k
01/22/2019 4 Gottesdiener Keith Michael (CEO & President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns: Sold 10,115 shares @ $30.01, valued at $303.6k
01/17/2019 4 Gottesdiener Keith Michael (CEO & President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns: Sold 662 shares @ $30, valued at $19.9k
12/06/2018 4 Gottesdiener Keith Michael (CEO and President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns: Sold 563 shares @ $30, valued at $16.9k
11/06/2018 4 Gottesdiener Keith Michael (CEO and President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns: Sold 16,500 shares @ $30.08, valued at $496.3k
06/22/2018 4 Gottesdiener Keith Michael (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns: Granted 1,787 shares @ $0
Granted 2,748 options to buy @ $85.12, valued at $233.9k
05/10/2018 4 Gottesdiener Keith Michael (C.E.O. and President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns: Exercised 3,000 options to buy @ $4.59, valued at $13.8k
04/09/2018 4 Gottesdiener Keith Michael (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS INC
Txns: Bought 1,171 shares @ $64, valued at $74.9k
02/16/2018 4 Gottesdiener Keith Michael (CEO & President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns: Granted 175,000 options to buy @ $25.79, valued at $4.5M
10/10/2017 4 Gottesdiener Keith Michael (CEO and President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns: Converted 27,262 shares @ $0
Converted 27,262 convertible preferred @ $0
10/04/2017 3 Gottesdiener Keith Michael (CEO and President) has filed a Form 3 on RHYTHM PHARMACEUTICALS, INC.
06/29/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
07/21/2016 4 Gottesdiener Keith Michael (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS INC
Txns: Granted 2,407 shares @ $0
Granted 3,196 options to buy @ $145.22, valued at $464.1k
07/21/2016 3 Gottesdiener Keith Michael (Director) has filed a Form 3 on INTERCEPT PHARMACEUTICALS INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy